1,151–1,200 of 20,598 genesranked by Most Researched

#	Gene	Name	Chr	Tags	PubMed Papers
1151	F9	coagulation factor IX	X	Highly ConstrainedProtease	302
1152	IGFBP2	insulin like growth factor binding protein 2	2	TrendingExperimental GO Evidence	302
1153	OPTN	optineurin	10	OMIM Disease GeneTrending	302
1154	RPS7	ribosomal protein S7	2	Highly ConstrainedFDA Approved Target	302
1155	STAU1	staufen double-stranded RNA binding protein 1	20	Highly ConstrainedTrending	302
1156	CXCL1	C-X-C motif chemokine ligand 1	4	TrendingExperimental GO Evidence	301
1157	DKC1	dyskerin pseudouridine synthase 1	X	Highly ConstrainedOMIM Disease Gene	301
1158	HNRNPA3	heterogeneous nuclear ribonucleoprotein A3	2	TrendingExperimental GO Evidence	301
1159	NPPA	natriuretic peptide A	1	OMIM Disease GeneExperimental GO Evidence	301
1160	PIM1	Pim-1 proto-oncogene, serine/threonine kinase	6	KinaseOncogene	301
1161	RYR2	ryanodine receptor 2	1	Ion ChannelReceptor	301
1162	SUMO2	small ubiquitin like modifier 2	17	TrendingExperimental GO Evidence	301
1163	ALPL	alkaline phosphatase, biomineralization associated	1	OMIM Disease GeneVariant-Rich	300
1164	DCTN1	dynactin subunit 1	2	TransporterOMIM Disease Gene	300
1165	GLA	galactosidase alpha	X	Highly ConstrainedFDA Approved Target	300
1166	GNB1	G protein subunit beta 1	1	Highly ConstrainedOMIM Disease Gene	300
1167	IRS2	insulin receptor substrate 2	13	Experimental GO EvidenceSwiss-Prot Reviewed	300
1168	PPP1CB	protein phosphatase 1 catalytic subunit beta	2	Highly ConstrainedOMIM Disease Gene	300
1169	PRDX6	peroxiredoxin 6	1	TrendingExperimental GO Evidence	300
1170	CCL3	C-C motif chemokine ligand 3	17	KinaseExperimental GO Evidence	299
1171	NHERF1	NHERF family PDZ scaffold protein 1	17	OMIM Disease GeneExperimental GO Evidence	299
1172	RPL13	ribosomal protein L13	16	Highly ConstrainedFDA Approved Target	299
1173	SMN2	survival of motor neuron 2, centromeric	5	FDA Approved TargetSwiss-Prot Reviewed	299
1174	CAD	carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase	2	OMIM Disease GeneVariant-Rich	298
1175	CEACAM5	CEA cell adhesion molecule 5	19	OncogeneFDA Approved Target	298
1176	CGAS	cyclic GMP-AMP synthase	6	DNA RepairExperimental GO Evidence	298
1177	KHSRP	KH-type splicing regulatory protein	19	Highly ConstrainedTransporter	298
1178	MCM5	minichromosome maintenance complex component 5	22	OMIM Disease GeneExperimental GO Evidence	298
1179	SF3B2	splicing factor 3b subunit 2	11	Highly ConstrainedOMIM Disease Gene	298
1180	SMC3	structural maintenance of chromosomes 3	10	DNA RepairHighly Constrained	298
1181	SOS1	SOS Ras/Rac guanine nucleotide exchange factor 1	2	Highly ConstrainedOMIM Disease Gene	298
1182	TCF3	transcription factor 3	19	OncogeneTranscription Factor	298
1183	RPA2	replication protein A2	1	DNA RepairHomologous Recombination	297
1184	RPS18	ribosomal protein S18	6	Highly ConstrainedExperimental GO Evidence	297
1185	THRB	thyroid hormone receptor beta	3	ReceptorFDA Approved Target	297
1186	ABCC8	ATP binding cassette subfamily C member 8	11	ReceptorTransporter	296
1187	CRHR1	corticotropin releasing hormone receptor 1	17	ReceptorFDA Approved Target	296
1188	GRIN1	glutamate ionotropic receptor NMDA type subunit 1	9	Ion ChannelReceptor	296
1189	RPL14	ribosomal protein L14	3	FDA Approved TargetExperimental GO Evidence	296
1190	RPS14	ribosomal protein S14	5	Highly ConstrainedFDA Approved Target	296
1191	RPS9	ribosomal protein S9	19	Highly ConstrainedFDA Approved Target	296
1192	RPTOR	regulatory associated protein of MTOR complex 1	17	Highly ConstrainedClinical Trials	296
1193	TFAP2A	transcription factor AP-2 alpha	6	Highly ConstrainedOMIM Disease Gene	296
1194	TXNIP	thioredoxin interacting protein	1	Tumor SuppressorTrending	296
1195	U2AF1	U2 small nuclear RNA auxiliary factor 1	21	OMIM Disease GeneExperimental GO Evidence	296
1196	ACLY	ATP citrate lyase	17	FDA Approved TargetExperimental GO Evidence	295
1197	ALYREF	Aly/REF export factor	17	Highly ConstrainedTransporter	295
1198	CUL2	cullin 2	10	Highly ConstrainedExperimental GO Evidence	295
1199	DIABLO	diablo IAP-binding mitochondrial protein	12	OMIM Disease GeneExperimental GO Evidence	295
1200	HTR2C	5-hydroxytryptamine receptor 2C	X	ReceptorFDA Approved Target	295